Michael-Bryant Hicks
Insider
First SEC filing: March 3, 2021 · Latest: March 3, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 2, 2021 | ELAN | F | 880 | $32.34 | $28,459 | 55,588 Direct | -1.56% | Disposed | -30.4% (price as of 2026-10-05) |
| March 1, 2021 | ELAN | F | 799 | $33.65 | $26,886 | 56,468 Direct | -1.40% | Disposed | -33.1% (price as of 2026-10-05) |
| Feb. 22, 2021 | ELAN | F | 6,533 | $30.58 | $199,779 | 57,267 Direct | -10.24% | Disposed | -26.4% (price as of 2026-10-05) |
| Feb. 22, 2021 | ELAN | A | 21,663 | · | · | 63,800 Direct | +51.41% | Acquired | (price as of 2026-10-05) |
| March 2, 2020 | ELAN | A | 9,000 | · | · | 42,137 Direct | +27.16% | Acquired | (price as of 2026-10-05) |
| March 1, 2020 | ELAN | F | 799 | $27.40 | $21,893 | 33,137 Direct | -2.35% | Disposed | -17.8% (price as of 2026-10-05) |
| Aug. 22, 2019 | ELAN | P | 11,030 | $26.65 | $293,950 | 33,936 Direct | +48.15% | Acquired | -15.5% (price as of 2026-10-05) |
| March 1, 2019 | ELAN | A | 8,181 | · | · | 22,906 Direct | +55.56% | Acquired | (price as of 2026-10-05) |
| Oct. 20, 2018 | ELAN | A | 29,383 | · | · | 29,383 Direct | · | Acquired | (price as of 2026-10-05) |
| Oct. 20, 2018 | ELAN | A | 9,725 | · | · | 14,725 Direct | +194.50% | Acquired | (price as of 2026-10-05) |
| Sept. 24, 2018 | ELAN | P | 5,000 | $24.00 | $120,000 | 5,000 Direct | · | Acquired | -6.2% (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 20, 2018 | ELAN | Non-Qualified Stock Option (Right-to-Buy) | Elanco Animal Health Inc. Common Stock | $31.61 | Oct. 20, 2028 | 29,383 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | · | · | · | · | · | · | · | · |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.